Scleroderma Market Size, Epidemiology, Leading Companies, Drugs And Competitive Analysis By DelveInsight
(Albany, US) DelveInsight has launched a new report on Scleroderma Market Insights, Epidemiology, and Market Forecast-2030.
DelveInsight's " Scleroderma
Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Scleroderma, historical and
forecasted epidemiology as well as the Scleroderma market trends in the United
States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of Scleroderma
facts:
·
In the United States, the prevalence of scleroderma is 240
per million and an annual incidence of 19 per million.
·
In Europe, the prevalence of scleroderma is estimated to be
between 10 and 150 per million people, while the annual incidence has been
reported to be between 3 and 28 per million people.
·
Women are four times more prone to develop systemic
scleroderma than men.
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/scleroderma-market
View
Report: https://www.delveinsight.com/report-store/scleroderma-market
Scope of Scleroderma
Reports:
- The
report covers the descriptive overview of Scleroderma, explaining its
causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Scleroderma epidemiology and treatment
in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Scleroderma are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Scleroderma market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Scleroderma market
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/scleroderma-market
View
Report: https://www.delveinsight.com/report-store/scleroderma-market
Scleroderma, or
systemic sclerosis, is a chronic connective tissue disease generally classified
as one of the autoimmune rheumatic diseases. It causes tissue throughout the
body, including the lungs and other organs, to thicken and scar. SSc-ILD is a
progressive lung disease in which lung function declines over time, and it can
be debilitating and life-threatening. ILD is the leading cause of death among
people with scleroderma, typically resulting from a loss of pulmonary function
that occurs when the lungs cannot supply enough oxygen to the heart.
Scleroderma is majorly of two types: localized scleroderma and systemic
sclerosis (SSc).
- Boehringer
Ingelheim International GmbH
- Corbus
Pharmaceuticals Holdings, Inc.
- Bayer
AG
- Gilead
Sciences, Inc.
- Allergan,
Inc.
- Pfizer,
Inc.
- Sanofi
- GlaxoSmithKline
plc
- Cumberland
Pharmaceuticals, Inc.
- Actelion
Pharmaceuticals, Inc.
- And
Many Others
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/scleroderma-market
View
Report: https://www.delveinsight.com/report-store/scleroderma-market
Table of
Contents:
1. Key Insights
2. Executive Summary of Scleroderma
3. Competitive Intelligence Analysis for
Scleroderma
4. Scleroderma: Market Overview at a
Glance
5. Scleroderma: Disease Background and
Overview
6. Patient Journey
7. Scleroderma Epidemiology and Patient
Population
8. Treatment Algorithm, Current
Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Scleroderma
Treatment
11. Marketed Products
12. Emerging Therapies
13. Scleroderma: Seven Major Market
Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of
Scleroderma
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Detailed
TOC: https://www.delveinsight.com/sample-request/scleroderma-market
View
Report: https://www.delveinsight.com/report-store/scleroderma-market
DelveInsght’s Competitive
Intelligence Service includes
a multidimensional coverage, helping to keep track of competitors and gain
traction in the dynamic market by overcoming the challenges and expediting
business growth through a strategic and tactical approach.
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight
Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment